Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature

References

• Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Annu Rev Med 2005;56:29–44.
   PubMed Web of Science ®Google Scholar
• Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 2005;56:155–167.
   PubMed Web of Science ®Google Scholar
• Leblond V, Choquet S. Lymphoproliferative disorders after liver transplantation. J Hepatol 2004;40:728–735.
   PubMed Web of Science ®Google Scholar
• Ben-Ari Z, Amlot P, Lachmanan SR, Tur-Kaspa R, Rolles K, Burroughs AK. Post-transplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome. Liver Transpl Surg 1999;5:184–191.
   PubMedGoogle Scholar
• Wu L, Rappaport DC, Hanbidge A, Merchant N, Shepherd FA, Greig PD. Lymphoproliferative disorders after liver transplantation: imaging features. Abdom Imaging 2001;26:200–206.
   PubMed Web of Science ®Google Scholar
• Lemoine A, Pham P, Azoulay D, et al Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants. Blood 2001;98:1332–1338.
   PubMed Web of Science ®Google Scholar
• Jain A, Nalesnik M, Reyes J, et al Post-transplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 2002;236:429–436; discussion 436–427.
   PubMed Web of Science ®Google Scholar
• Duvoux C, Pageaux GP, Vanlemmens C, et al Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients. Transplantation 2002;74:1103–1109.
   PubMed Web of Science ®Google Scholar
• Kremers WK, Devarbhavi HC, Wiesner RH, Krom RA, Macon WR, Habermann TM. Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival. Am J Transplant 2006;6:1017–1024.
   PubMed Web of Science ®Google Scholar
• Avolio AW, Agnes S, Barbarino R, et al Post-transplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series. Transplant Proc 2007;39:1956–1960.
   PubMed Web of Science ®Google Scholar
• Patel H, Vogl DT, Aqui N, et al Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases. Leuk Lymphoma 2007;48:885–891.
   PubMed Web of Science ®Google Scholar
• Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A. Post-transplantation lymphoproliferative disorder–the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus. Liver Transpl 2007;13:904–912.
   PubMed Web of Science ®Google Scholar
• Dhillon MS, Rai JK, Gunson BK, Olliff S, Olliff J. Post-transplant lymphoproliferative disease in liver transplantation. Br J Radiol 2007;80:337–346.
   PubMed Web of Science ®Google Scholar
• Brown RS Jr. Live donors in liver transplantation. Gastroenterology 2008;134:1802–1813.
   PubMed Web of Science ®Google Scholar
• Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002;346:1074–1082.
   PubMed Web of Science ®Google Scholar
• Kawano N, Shimoda K, Ishikawa F, et al Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation. Transplantation 2006;82:840–843.
   PubMed Web of Science ®Google Scholar
• Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995;333:333–336.
   PubMed Web of Science ®Google Scholar
• Cosio FG, Grande JP, Larson TS, et al Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant 2005;5:1130–1136.
   PubMed Web of Science ®Google Scholar
• Krieger NR, Becker BN, Heisey DM, et al Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation 2003;75:1677–1682.
   PubMed Web of Science ®Google Scholar
• Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation 2003;75:2001–2007.
   PubMed Web of Science ®Google Scholar
• Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation. Transplantation 2003;76:1599–1603.
   PubMed Web of Science ®Google Scholar
• Weiss S, Kotsch K, Francuski M, et al Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007;7:1584–1593.
   PubMed Web of Science ®Google Scholar
• Raymond E, Tricottet V, Samuel D, Reynes M, Bismuth H, Misset JL. Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation. Cancer 1995;76:1344–1351.
   PubMed Web of Science ®Google Scholar
• Dulundu E, Sugawara Y, Makuuchi M. Revolution and refinement of surgical techniques for living donor partial liver transplantation. Yonsei Med J 2004;45:1076–1088.
   PubMed Web of Science ®Google Scholar
• Tamura S, Sugawara Y, Kishi Y, et al Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus: a single-center experience at the University of Tokyo. Transplant Proc 2004;36:3242–3244.
   PubMed Web of Science ®Google Scholar
• Terminology for hepatic allograft rejection. International Working Party. Hepatology 1995;22:648–654.
   PubMedGoogle Scholar
• Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997;25:658–663.
   PubMed Web of Science ®Google Scholar
• Akamatsu N, Sugawara Y, Kaneko J, Kishi Y, Makuuchi M. Risk factors of cytomegalovirus infection after living donor liver transplantation. Hepatogastroenterology 2005;52:197–199.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
   Google Scholar
• Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood 2004;104:3009–3020.
   PubMed Web of Science ®Google Scholar
• Dotti G, Fiocchi R, Motta T, et al Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant. Transplantation 2000;69:827–833.
   PubMed Web of Science ®Google Scholar
• Ghobrial IM, Habermann TM, Macon WR, et al Differences between early and late post-transplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases? Transplantation 2005;79:244–247.
   PubMed Web of Science ®Google Scholar
• de Jonge J, Kurian S, Shaked A, et al Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts. Am J Transplant 2009;9:758–772.
   PubMed Web of Science ®Google Scholar
• van Leeuwen MT, Grulich AE, Webster AC, et al Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood 2009;114:630–637.
   PubMed Web of Science ®Google Scholar
• Aucejo F, Rofaiel G, Miller C. Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation? J Hepatol 2006;44:19–23.
   PubMed Web of Science ®Google Scholar
• Morton LM, Landgren O, Chatterjee N, et al Hepatitis C virus infection and risk of post-transplantation lymphoproliferative disorder among solid organ transplant recipients. Blood 2007;110:4599–4605.
   PubMed Web of Science ®Google Scholar
• Maecker B, Jack T, Zimmermann M, et al CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation. J Clin Oncol 2007;25:4902–4908.
   PubMed Web of Science ®Google Scholar
• Oertel SH, Verschuuren E, Reinke P, et al Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant 2005;5:2901–2906.
   PubMed Web of Science ®Google Scholar
• Choquet S, Leblond V, Herbrecht R, et al Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood 2006;107:3053–3057.
   PubMed Web of Science ®Google Scholar
• Mamzer-Bruneel MF, Lome C, Morelon E, et al Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: a report of 16 cases observed in a single center. J Clin Oncol 2000;18:3622–3632.
   PubMed Web of Science ®Google Scholar